|The Staphylococcus aureus Enterotoxin n/a (Catalog #MBS310415) is an Antibody produced from Host: Mouse. Hybridization of X63-Ag8-653 myeloma cells with spleen cells from BALB/c mice.
Source: Ascites and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Staphylococcus aureus Enterotoxin can be used in a range of immunoassay formats including, but not limited to, EIA/ELISA, Western Blot.
Detection of staphylococcal enterotoxins in indirect ELISA and Western blot. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessa. Researchers should empirically determine the suitability of the Staphylococcus aureus Enterotoxin n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Purified enterotoxin A from FRI-722H strain of St. aureus
Affinity Constant: Not determined. Buffer: PBS, pH 7.4
Preservative: 0.1% Sodium azide
Important Note: Centrifuge before opening to ensure complete recovery of vial contents.
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Staphylococcus aureus Enterotoxin are readily searchable from our website. Different antibodies against the same target such as Staphylococcus aureus Enterotoxin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.